Application of hepatobiliary-specific MRI contrast agent Gd-EOB-DTPA in preoperative evaluation of hepatobiliary patients
-
摘要: 钆塞酸二钠(Gd-EOB-DTPA)是一种新型肝细胞特异性对比剂,经胆道和肾脏双通道排泄,具有非特异性细胞外对比剂和肝细胞特异性对比剂的双重特点,将动态期成像和肝胆特异期成像的特点结合可清晰地显示肝脏局灶性病变,可以在相对短的时间内对肝脏血流灌注、胆管成像、定性和检测肝脏局灶性病变、评估肝功能。国内外大量研究已证实肝胆特异性磁共振检查在肝癌尤其是小肝癌的定性诊断中明显优于磁共振成像、增强CT及超声检查。介绍了该对比剂的特点、在肝胆手术术前评估中的应用现状及展望。Abstract: Gd- EOB- DTPA,a newly applicable hepatocyte- specific contrast agent,is excreted through the biliary tract and the kidney,showing the characteristics of nonspecific extracellular contrast agent and hepatocyte- specific contrast agent. It can provide both dynamic and hepatobiliary images and has been rapidly accepted by clinicians for the diagnosis of liver lesions and preoperative evaluation. Gd- EOB-DTPA can fulfill hepatic perfusion imaging,cholangiography,detection and characterization of focal liver lesions,and evaluation of liver function within the same examination in a relatively short time window. A large number of domestic and foreign studies have confirmed that hepatobiliary- specific contrast- enhanced MRI is significantly superior to MRI scan,contrast- enhanced CT,and ultrasound in diagnosing hepatocellular carcinoma,especially small hepatocellular carcinoma. The features of Gd- EOB- DTPA and its current status and prospect of application in the preoperative evaluation of hepatocellular carcinoma are reviewed in this article.
-
Key words:
- liver neoplasms /
- magetic resonance imaging /
- contrast media /
- Gd-EOB-DTPA /
- review
-
[1]PURYSKO AS,REMER EM,VENIERO JC.Focal liver lesion detection and characterization with GD-EOB-DTPA[J].Clin Radiol,2011,66(7):673-684. [2]FRERICKS BB,LODDENKEMPER C,HUPPERTZ A,et al.Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA[J].AJR Am J Roentgenol,2009,193(4):1053-1060. [3]CHANYAPUTHIPONG J,LOW SC,CHOW PK.Gadoxetate acid-Enhanced MR imaging for HCC:a review for clinicians[J].Int J Hepatol,2011,2011:489342. [5]GOLFIERI R,RENZULLI M,LUCIDI V,et al.Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small(≤2 cm)HCC in cirrhosis[J].Eur Radiol,2011,21(6):1233-1242. [6]LEE JH,LEE JM,KIM SJ,et al.Enhancement patterns of hepatocellular carcinomas on multiphasic multidetector row CT:comparison with pathological differentiation[J].Br J Radiol,2012,85(1017):e573-e583. [7]LEE SA,LEE CH,JUNG WY,et al.Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI:initial experience[J].Magn Reson Imaging,2011,29(1):83-90. [8]NARITA M,HATANO E,ARIZONO S,et al.Expression of OATP1B3determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma[J].J Gastroenterol,2009,44(7):793-798. [9]ZECH CJ,GRAZIOLI L,JONAS E,et al.Health-economic evaluation of three imaging strategies in patients with suspected colorectal liver metastases:Gd-EOB-DTPA-enhanced MRI vs.extracellular contrast media-enhanced MRI and 3-phase MDCT in Germany,Italy and Sweden[J].Eur Radiol,2009,19(Suppl 3):s753-s763. [10]RIMOLA J,FORNER A,REIG M,et al.Cholangiocarcinoma in cirrhosis:Absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma[J].Hepatology,2009,50(3):791-798. [11]DOO KW,LEE CH,CHOI JW,et al.“Pseudo washout”sign in high-flow hepatic hemangioma on gadoxetic acid contrast-en-hanced MRI mimicking hypervascular tumor[J].AJR Am J Roentgenol,2009,193(6):w490-w496. [12]ZECH CJ,GRAZIOLI L,BREUER J,et al.Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging:results of a multicenter trial[J].Invest Radiol,2008,43(7):504-511. [13]TANIMOTO A,MIN LEE J,MURAKAMI T,et al.Consensus report of the 2nd International Forum for Liver MRI[J].Eur Radiol,2009,19(Suppl 5):975-989. [14]van BEERS BE,PASTOR CM,HUSSAIN HK.Primovist,Eovist:what to expect?[J].J Hepatol,2012,57(2):421-429. [15]LEE NK,KIM S,LEE JW,et al.Biliary MR imaging with GdEOB-DTPA and its clinical applications[J].Radiographics,2009,29(6):1707-1724. [16]LLADL,FIGUERAS J,MEMBA R,et al.Is MELD really the definitive score for liver allocation?[J].Liver Transpl,2002,8(9):795-798. [17]LI JF,HU YQ,HE SQ.Research progress in evaluation of liver reserve founction[J].China Med Heral,2013,10(24):41-44.(in Chinese)李江发,胡虞乾,何松青.肝脏储备功能评估的研究进展[J].中国医药导报,2013,10(24):41-44. [18]TANG F,LIU H.Research developrnent of Gd-EOB-DTPA in evaluation of liver function[J].Chin J Med Imaging Tednol,2014,30(6):939-942.(in Chinese)唐菲,刘辉.新型磁共振对比剂Gd-EOB-DTPA用于评估肝功能研究进展[J].中国医学影像技术,2014,30(6):939-942. [19]RYEOM H,KIM S,KIM J,et al.Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA[J].Korean J Radiol,2004,5(4):231-239. [20]JIANG J,YE JJ,LIU GY,et al.Visualization of the biliary ducts on contrast enhanced MR chlangiography with Gd-EOB-DTPA:reloation with liver function in patients with liver cirrhosis[J].Chin J Med Imaging Tednol,2013,29(5):765-769.(in Chinese)蒋健,叶健军,刘光耀,等.Gd-EOB-DTPA增强MR胆管成像对胆管的显示与肝硬化患者肝功能的关系[J].中国医学影像技术,2013,29(5):765-769. [21]KATSUBE T,OKADA M,KUMANO S,et al.Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging[J].Invest Radiol,2011,46(4):277-283. [22]YAMADA A,HARA T,LI F,et al.Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging[J].Radiology,2011,260(3):727-733. [23]TAJIMA T,TAKAO H,AKAI H,et al.Relationship between liver function and liver signal intensity in hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging[J].J Comput Assist Tomogr,2010,34(3):362-366.
本文二维码
计量
- 文章访问数: 2622
- HTML全文浏览量: 16
- PDF下载量: 632
- 被引次数: 0